1. Home
  2. CLRO vs BCDA Comparison

CLRO vs BCDA Comparison

Compare CLRO & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ClearOne Inc. (DE)

CLRO

ClearOne Inc. (DE)

HOLD

Current Price

$5.34

Market Cap

14.4M

Sector

Technology

ML Signal

HOLD

Logo BioCardia Inc.

BCDA

BioCardia Inc.

HOLD

Current Price

$0.85

Market Cap

13.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLRO
BCDA
Founded
1983
N/A
Country
United States
United States
Employees
N/A
21
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.4M
13.6M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
CLRO
BCDA
Price
$5.34
$0.85
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
8.2M
588.4K
Earning Date
05-18-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$46,067,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.59
N/A
52 Week Low
$2.71
$0.78
52 Week High
$16.50
$2.37

Technical Indicators

Market Signals
Indicator
CLRO
BCDA
Relative Strength Index (RSI) 46.01 41.61
Support Level $4.01 $0.81
Resistance Level $5.62 $1.29
Average True Range (ATR) 2.51 0.09
MACD -0.38 -0.01
Stochastic Oscillator 0.79 14.32

Price Performance

Historical Comparison
CLRO
BCDA

About CLRO ClearOne Inc. (DE)

ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: